findmyKOL

John Vavalle, MD

Basic profile

University of North Carolina at Chapel Hill

ORCIDNPI
RegionChapel Hill, NC · SoutheastSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

John Vavalle is a Cardiology physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 201 publications with 2,386 citations (h-index 26).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
201publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,386citations

Total citations across indexed works.

26h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
23companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

101 Manning Dr
Rm 1107g W Wing
Chapel Hill, NC 275990001

Telephone

919-966-4996

Registry record last updated 10 Jan 2017.

View the NPPES registry record

Industry payments

23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    77.1%
    Beta blocker16.3%
    Metoprolol Succinate72%Carvedilol28%
    Part D43 patients
    Statin16%
    Atorvastatin Calcium88%Rosuvastatin Calcium12%
    Part D<11 patients

    + 12 more classes in this area

  • Blood & clotting

    14.3%
    Factor Xa inhibitor9.6%
    Eliquis100%
    Part D27 patients
    P2Y12 inhibitor4.7%
    Clopidogrel100%
    Part D18 patients
  • Metabolism & gastrointestinal

    4.6%
    SGLT2 inhibitor4.6%
    Jardiance100%
    Part D18 patients
Where care is delivered (Part B)60.1% facility · 39.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”